These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11963293)

  • 1. [Our cytochrome P450: a waste-disposal enterprise much in demand].
    Eyer P
    Anaesthesist; 2002 Jan; 51(1):1. PubMed ID: 11963293
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cytochrome P-450 system].
    Spigset O
    Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3296-8. PubMed ID: 11826461
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics.
    Morgan ET
    Clin Pharmacol Ther; 2009 Apr; 85(4):434-8. PubMed ID: 19212314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinically relevant adverse drug interactions].
    Martin-Facklam M; Haefeli WE
    Ther Umsch; 2000 Sep; 57(9):579-83. PubMed ID: 11036439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450: drug metabolism--why it's so important to understand.
    Byrd L; Luther C
    Geriatr Nurs; 2010; 31(5):385-7. PubMed ID: 20960692
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytochrome p450 and their implication in chemotherapy].
    Delwaide PA
    Rev Med Liege; 1998 Nov; 53(11):700-10. PubMed ID: 9887664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [50 years of cytochrome P450. Drug metabolism - from past to present].
    Saussele T
    Med Monatsschr Pharm; 2014 Aug; 37(8):295-8. PubMed ID: 25158378
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug essentials. The cytochrome P450 microenzyme system and targeted therapies: Minimizing drug interactions.
    Wilkes GM
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl Nurse Ed):33, 52-6. PubMed ID: 19856586
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?
    Tang C; Lin JH; Lu AY
    Drug Metab Dispos; 2005 May; 33(5):603-13. PubMed ID: 15673596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
    Martinez MN; Antonovic L; Court M; Dacasto M; Fink-Gremmels J; Kukanich B; Locuson C; Mealey K; Myers MJ; Trepanier L
    Drug Metab Rev; 2013 May; 45(2):218-30. PubMed ID: 23432217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism and drug interactions in the elderly.
    Herrlinger C; Klotz U
    Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):897-918. PubMed ID: 11866484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics in Critical Care.
    Cheek D; Howington L
    AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of portal shunts on intestinal cytochrome P450 3A activity.
    Rostami-Hodjegan A; Tucker GT
    Hepatology; 2002 Jun; 35(6):1549-50; author reply 1550-1. PubMed ID: 12029646
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.